• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RENEGADE HI-FLO KIT; CATHETER, CONTINUOUS FLUSH

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RENEGADE HI-FLO KIT; CATHETER, CONTINUOUS FLUSH Back to Search Results
Model Number 29460
Medical Device Problem Codes Difficult to Advance (2920); Material Integrity Problem (2978)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 06/19/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that coating issue occurred.The target lesion was located in the vessel of the liver.A 135/10 renegade hi-flo kit was selected for transcatheter arterial chemoembolization (tace).However, after flushing with normal saline, it was noted that the surface of hydrophilic coting was rough, and the device could not cross the 5f imaging catheter to the lesion.The procedure was completed with another of the same device.No complications were reported and the patient was stable post-procedure.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the complaint device was received for product analysis.Inspection of the device revealed multiple slight shaft kinks; however, the kinks did not disrupt functional testing of the device.An.018-inch guidewire was received with the device and used to perform a guidewire insertion test.The device was flushed, and the guidewire passed with no issues.A test 5 fr guide catheter was used to perform an interaction test, and the device was flushed and passed through the device with no issues.No other issues were identified during the product analysis.Analysis of the device was unable to confirm the clinical observations.
 
Event or Problem Description
It was reported that coating issue occurred.The target lesion was located in the vessel of the liver.A 135/10 renegade hi-flo kit was selected for transcatheter arterial chemoembolization (tace).However, after flushing with normal saline, it was noted that the surface of hydrophilic coting was rough, and the device could not cross the 5f imaging catheter to the lesion.The procedure was completed with another of the same device.No complications were reported and the patient was stable post-procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RENEGADE HI-FLO KIT
Common Device Name
CATHETER, CONTINUOUS FLUSH
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
model farm road
cork T12 Y K88
EI   T12 YK88
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key19723914
Report Number2124215-2024-41577
Device Sequence Number20901603
Product Code KRA
UDI-Device Identifier08714729280774
UDI-Public08714729280774
Combination Product (Y/N)N
Initial Reporter CountryCH
PMA/510(K) Number
K140329
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Other,Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 09/09/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date07/04/2025
Device Model Number29460
Device Catalogue Number29460
Device Lot Number0032156693
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 06/19/2024
Supplement Date Received by Manufacturer08/15/2024
Initial Report FDA Received Date07/11/2024
Supplement Report FDA Received Date09/09/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured08/04/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age57 YR
Patient SexMale
Patient Weight65 KG
-
-